1700024P16Rik Inhibitors is a group of compounds proposed to interact with the protein encoded by the gene 1700024P16Rik. The exact nature and structure of these inhibitors are not clearly defined due to the limited understanding of the protein's biological function and involvement in cellular pathways. These inhibitors encompass a wide array of chemical structures and properties, each postulated to modulate the activity of 1700024P16Rik in a cell. The inhibitors act through various biochemical mechanisms, such as directly binding to the protein, altering its conformation, affecting its enzymatic activity, or disrupting its interaction with other cellular components. Considering the protein's unknown role, the inhibitors could target a range of functionalities, from specific signaling pathways to broader cellular processes like gene expression, metabolic regulation, or cellular signaling.
Developing and characterizing 1700024P16Rik Inhibitors would involve an interdisciplinary approach, incorporating elements of molecular biology, chemistry, and computational biology. Researchers utilize advanced computational methods to model the protein structure and predict potential binding sites for these inhibitors. This would be followed by synthetic chemistry efforts to design and produce the molecules, which could range from small, targeted compounds to more complex molecular structures. Experimental validation in biochemical assays and cellular studies would be essential to determine the actual impact of these inhibitors on the protein's function. This research would be iterative, with continuous refinement of the inhibitors and an evolving understanding of the protein's role within the cell. Exploring this class of inhibitors not only aids in understanding the specific protein in question but also enhances broader knowledge in cellular biochemistry and molecular biology, shedding light on the intricate network of interactions that govern cellular functions.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
A kinase inhibitor, potentially affecting phosphorylation processes, which are fundamental in many signaling pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, could impact the PI3K/Akt signaling pathway, a key pathway in many cellular functions. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, might affect cell growth and autophagy, which are important in various cellular processes. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitor, could affect gene expression and chromatin structure, influencing numerous proteins. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibitor of the MAPK/ERK pathway, potentially affecting cell signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor, potentially impacting stress response and apoptosis pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
PI3K inhibitor, could affect various signaling pathways. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, might influence protein degradation, crucial in many cellular processes. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Calcium channel blocker, could impact calcium signaling, vital in many cellular functions. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
HDAC inhibitor, could influence gene expression processes. | ||||||